The Ukrainian Factor in Early-Stage Drug Discovery in the Context of Russian Invasion: The Case of Enamine Ltd
ACS Med. Chem. Lett. 2022, 13 (7), 992-996
Kondratov I.; Moroz Y.; Grygorenko O.; Tolmachev A.
Ukrainian companies occupy an important niche in the global drug discovery process; however, before the Russian invasion, the role of Ukraine was not obvious. The biggest Ukrainian fine chemical supplier, Enamine Ltd, had to stop operation for more than a month, which significantly affected various early-stage drug discovery projects. The role of Enamine in drug discovery and the company’s past and future in the context of the Russian invasion are described in this Viewpoint.